Daniel J. Burdick
Publications by Year
Research Areas
Computational Drug Discovery Methods, Peptidase Inhibition and Analysis, Parkinson's Disease Mechanisms and Treatments, Chemical Synthesis and Analysis, Cell Adhesion Molecules Research
Most-Cited Works
- → Ser 1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations(2012)373 cited
- → Generation of an LFA-1 Antagonist by the Transfer of the ICAM-1 Immunoregulatory Epitope to a Small Molecule(2002)169 cited
- → Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors(2012)161 cited
- → Cyclic RGD peptide analogs as antiplatelet antithrombotics(1992)160 cited
- → Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors(2013)123 cited
- → Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains(2016)118 cited
- → Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial(2023)113 cited
- → Engineering subtilisin BPN′ for site‐specific proteolysis(1989)108 cited
- → Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling(2012)79 cited
- → Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation.(1995)77 cited